Prescott Group Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,500
| Closed | -$1.2M | – | 257 |
|
|
2024
Q4 | $1.2M | Hold |
6,500
| – | – | 0.16% | 161 |
|
|
2024
Q3 | $1.28M | Hold |
6,500
| – | – | 0.19% | 143 |
|
|
2024
Q2 | $1.34M | Hold |
6,500
| – | – | 0.21% | 132 |
|
|
2024
Q1 | $1.76M | Hold |
6,500
| – | – | 0.28% | 107 |
|
|
2023
Q4 | $1.54M | Hold |
6,500
| – | – | 0.27% | 107 |
|
|
2023
Q3 | $1.27M | Hold |
6,500
| – | – | 0.28% | 101 |
|
|
2023
Q2 | $1.37M | Buy |
6,500
+2,000
| +44% | +$421K | 0.3% | 102 |
|
|
2023
Q1 | $908K | Hold |
4,500
| – | – | 0.21% | 118 |
|
|
2022
Q4 | $981K | Buy |
+4,500
| New | +$981K | 0.21% | 113 |
|
|
2022
Q1 | – | Sell |
-2,500
| Closed | -$942K | – | 151 |
|
|
2021
Q4 | $942K | Sell |
2,500
-118
| -5% | -$44.5K | 0.21% | 121 |
|
|
2021
Q3 | $1.08M | Buy |
2,618
+50
| +2% | +$20.6K | 0.3% | 103 |
|
|
2021
Q2 | $950K | Buy |
2,568
+68
| +3% | +$25.2K | 0.27% | 89 |
|
|
2021
Q1 | $725K | Buy |
+2,500
| New | +$725K | 0.21% | 98 |
|
|
2020
Q2 | – | Sell |
-3,029
| Closed | -$382K | – | 97 |
|
|
2020
Q1 | $382K | Buy |
+3,029
| New | +$382K | 0.19% | 90 |
|
|
2015
Q3 | – | Sell |
-16,884
| Closed | -$1.19M | – | 169 |
|
|
2015
Q2 | $1.19M | Hold |
16,884
| – | – | 0.24% | 114 |
|
|
2015
Q1 | $1.34M | Buy |
16,884
+6,083
| +56% | +$482K | 0.27% | 105 |
|
|
2014
Q4 | $687K | Buy |
+10,801
| New | +$687K | 0.11% | 157 |
|